The Serum Institute of India (CII) has made the vaccine prices public after allowing the central government’s state governments and private hospitals to purchase the vaccine directly from the vaccine manufacturers.
CII tweeted, praising the decision of the Central Government that in the next two months it will increase the production of vaccine in limited quantity, out of which 50% will be for the Government of India and the remaining 50% will be provided by the State Governments and Private Hospitals.
AstraZeneca and Oxford’s vaccine is produced under the name CII covishield. CII has kept a dose of Rs 400 for state governments and Rs 600 for private hospitals.
At the same time, the company has compared the prices of the foreign vaccine to the price of the Indian vaccine. The CII has said that the cost of the American vaccine is 1500 rupees, the Russian vaccine costs 750 rupees and the Chinese vaccine costs 750 rupees.
Along with this, CII has asked corporate and private companies to get the vaccine from the government machinery and private health system. The vaccine will be available in the market in the next four-five months.
CII is giving a dose of covishield to the Central Government for 150 rupees which will continue to be given in the same way.
The central government had allowed vaccination of covid-19 for people over 18 years of age from 1 May, after which the central government also allowed state governments and private hospitals to purchase the vaccine themselves.
At the same time, the Government of India has announced a grant amount of Rs 4,500 crore to CII and Covaxin manufacturing company Bharat Biotech.
CII chief Adar Poonawala has said that vaccine production will pick up and by the end of May there will be 15-20% more covishields in the market.
Poonawala has said that his company will be able to produce 100 million doses every month after July.